Stock Groups

U.S. Senate to vote on lowering insulin prices this spring -Sen. Schumer -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – A type 1 diabetes advocate in the United States displays lower cost insulin purchased at a Canadian pharmacy, London, Ontario Canada, June 29, 2019. REUTERS/Carlos Osorio

WASHINGTON, (Reuters) – U.S. Senate Majority leader Chuck Schumer stated Tuesday that he plans to vote this spring on a bill which would limit the price of insulin. This is a life-sustaining drug for diabetes.

Schumer indicated that the bill would establish a 35-month cap on insulin payments for patients. Schumer also said the plan would pair with an emerging bipartisan plan “in order to reduce the price in a more comprehensive fashion, such as having the uninsured insured protected.”

After a recess in April, the Democratic leader said that he was working on putting the legislation before the Senate floor.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]